// App-Quantinova.ai

2184 : An Economic Evaluation on the Impact of Earlier Systemic Lupus Erythematosus (SLE) Diagnosis Using Complement C4d Activation Products in a Multivariate Assay Panel (MAP)

Researchers

Presenter

  • Tom Goss

Principal Investigators

  • Andrew Piscitello

  • Tarun Chandra

  • Tyler O'Malley

  • Thierry Dervieux

  • Tami Powell

Medical Centers

  • Division of Nephrology, University of Calgary, Calgary, AB, Canada

  • Health Economics Outcomes Research, Boston Healthcare, Boston, MA

  • EmpiriQA LLC, Long Grove, IL

  • Exagen Diagnostics, Vista, CA

  • Corporate Payer Strategy & Reimbursement, Exagen Diagnostics, Inc., vista, CA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved